A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir
Lumley SF. et al, (2024), Journal of Clinical Virology, 174, 105711 - 105711
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711.
Lumley SF. et al, (2024), Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 174
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy
Lumley S. et al, (2024), Sexually Transmitted Infections, 100, 329 - 331
Peer support for people living with hepatitis B virus—A foundation for treatment expansion
Downs LO. et al, (2024), Journal of Viral Hepatitis, 31, 490 - 499
Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?
Im YR. et al, (2024), Sexually Transmitted Infections, 100, 259 - 263
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection
Delphin M. et al, (2024), The Lancet Gastroenterology & Hepatology, 9, 383 - 392
Evaluation of sequence hybridization for respiratory viruses using the Twist Bioscience Respiratory Virus Research panel and the OneCodex Respiratory Virus sequence analysis workflow
Kapel N. et al, (2023), Microbial Genomics, 9